Faster screening for cancer drugs

Anja BielinskyCancer is a genetic disease, occurring when inherited or environmental factors corrupt the DNA in cells.

Although scientists have made strides in understanding cancer’s genetic roots, current technologies limit their capacity to understand the complexities of mutations and efficiently find therapies that work.  

That’s why Masonic Scholar and U biochemistry faculty member Anja Bielinsky, Ph.D., is working to create powerful tools that track how suspicious genes both mutate and respond to anti-cancer drugs.  

In 2017, Bielinsky’s team achieved a major milestone by launching a cell library that they have used to trigger and track cancer-mimicking mutations in suspect genes. So far, they have disrupted 1,000 genes that are potential cancer culprits and inserted barcodes to track the mutations.

In 2018, they secured a grant from the National Science Foundation, which when combined with Masonic support, will allow them to take the next big step in their work. Their plan is to complete 25 to 50 anti-cancer drug screens and track which mutations are more vulnerable or resistant to the drugs. This work could significantly expedite the discovery of targeted therapies—while the current standard in drug screening is to test numerous compounds against one defective cell at a time, Bielinsky’s screens will test just as many compounds against hundreds of defective cells at a time.  

Without Masonic support, which has allowed Bielinsky to hire experienced scientists to her team, this work would not be where it is today.


Balbo Lab
In addition to causing side effects such as vomiting or hair loss, chemotherapy is thought to play a significant role in how patients respond to... Read more
David Potter
With Masonic support, David Potter, M.D., Ph.D., a hematology, oncology, and transplantation faculty member, is working to improve outcomes for women... Read more
Fiona He Featured
T cells are immune cells that play a vital role in keeping the body healthy. But when T cells become dysfunctional, it can increase susceptibility to... Read more